Last night, the National Institutes of Health (NIH) in the US issued a statement claiming that hospitalised patients with advanced Covid-19 who received remdesivir recovered faster than similar patients who received a placebo, according to preliminary data from an RCT. The Medical Research Council’s (MRC) clinical trials unit is running the EU arm of this trial and the SMC invited the scientists involved to talk about these preliminary results and answer journalist’s questions.
Prof Mahesh Parmar, Director of the MRC Clinical Trials Unit at UCL
Prof Abdel Babiker, Professor of Epidemiology and Medical Statistics at the MRC Clinical Trials Unit at UCL and co-lead for this study
Prof Brian Angus, Professor of Infectious Diseases at the Nuffield Department of Clinical Medicine, University of Oxford and the Director of the Oxford Centre for Clinical Tropical Medicine and Global Health, and study site PI at the Churchill Hospital
Two SMC Roundups on the results from this trial were also issued here and here.